Strides Pharma Science (Strides) today announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. , Singapore, has received approval for the generic version of Theophylline Extended-Release Tablets, 300 mg and 450 mg, from the United States Food & Drug Administration (USFDA).
| Subscribe To Our Free Newsletter |
